New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) continue to represent a challenge for clinicians and public health authorities. Unfortunately, although there have been encouraging reports of higher success rates, the overall rate of favorable outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Denise Rossato, Dalcolmo, Margareth, Tiberi, Simon, Arbex, Marcos Abdo, Munoz-Torrico, Marcela, Duarte, Raquel, D’Ambrosio, Lia, Visca, Dina, Rendon, Adrian, Gaga, Mina, Zumla, Alimuddin, Migliori, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044661/
https://www.ncbi.nlm.nih.gov/pubmed/29791557
http://dx.doi.org/10.1590/S1806-37562017000000436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044661/
https://www.ncbi.nlm.nih.gov/pubmed/29791557
http://dx.doi.org/10.1590/S1806-37562017000000436

Ejemplares similares